A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report
Authors:
- Fateme ZiyaeeFZFateme Ziyaee
- Eslam ShorafaESEslam Shorafa
- Hassan DastsoozHDHassan Dastsooz
- Parham HabibzadehParham Habibzadeh
- Hamid NematiHNHamid Nemati
- Amir SaeedASAmir Saeed
- Mohammad SilawiMSMohammad Silawi
- Mohammad Ali Farazi FardMFMohammad Ali Farazi Fard
- Mohammad Ali FaghihiMFMohammad Ali Faghihi
- Seyed Alireza DastgheibSDSeyed Alireza Dastgheib
Open Access
- 14 January 2019
- journal article
- case report
- Published by Springer Nature in BMC Medical Genetics
- Vol. 20 (1) , 1-6
Abstract
Muscular dystrophies are a clinically and genetically heterogeneous group of disorders characterized by variable degrees of progressive muscle degeneration and weakness. There is a wide variability in the age of onset, symptoms and rate of progression in subtypes of these disorders. Herein, we present the results of our study conducted to identify the pathogenic genetic variation involved in our patient affected by rigid spine muscular dystrophy. A 14-year-old boy, product of a first-cousin marriage, was enrolled in our study with failure to thrive, fatigue, muscular dystrophy, generalized muscular atrophy, kyphoscoliosis, and flexion contracture of the knees and elbows. Whole-exome sequencing (WES) was carried out on the DNA of the patient to investigate all coding regions and uncovered a novel, homozygous missense mutation in SEPN1 gene (c. 1379 C > T, p.Ser460Phe). This mutation has not been reported before in different public variant databases and also our database (BayanGene), so it is classified as a variation of unknown significance (VUS). Subsequently, it was confirmed that the novel variation was homozygous in our patient and heterozygous in his parents. Different bioinformatics tools showed the damaging effects of the variant on protein. Multiple sequence alignment using BLASTP on ExPASy and WebLogo, revealed the conservation of the mutated residue. We reported a novel homozygous mutation in SEPN1 gene that expands our understanding of rigid spine muscular dystrophy. Although bioinformatics analyses of results were in favor of the pathogenicity of the mutation, functional studies are needed to establish the pathogenicity of the variant.Keywords
Funding Information
- NIMAD (940714)
This publication has 39 references indexed in Scilit:
- The ever‐expanding spectrum of congenital muscular dystrophiesAnnals of Neurology, 2012
- Disorders of selenium metabolism and selenoprotein functionCurrent Opinion in Pediatrics, 2011
- SEPN1 -related myopathiesNeurology, 2011
- Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic populationBrain, 2009
- Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursorsBMC Developmental Biology, 2009
- A mutation in theSEPN1selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads toSEPN1-related myopathyHuman Mutation, 2009
- Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscleProceedings of the National Academy of Sciences, 2008
- Congenital muscular dystrophies: New aspects of an expanding group of disordersBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- A single homozygous point mutation in a 3′untranslated region motif of selenoprotein N mRNA causes SEPN1‐related myopathyEMBO Reports, 2006
- The muscular dystrophiesThe Lancet, 2002